Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Cardiology Reports
Erschienen in: Current Cardiology Reports 9/2018

01.09.2018 | Public Health Policy (E Klodas, Section Editor)

Coronary Artery Calcium Score: the “Mammogram” of the Heart?

verfasst von: Miguel Cainzos-Achirica, Philip A. Di Carlo, Catherine E. Handy, Renato Quispe, Gerard Roura, Xavier Pinto, Roger S. Blumenthal, Josep Comin-Colet, Xavier Corbella, Michael J. Blaha

Erschienen in: Current Cardiology Reports | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To discuss the classic analogy of “coronary artery calcium (CAC) as a mammogram of the heart”, by evaluating the conceptual strengths, weaknesses, opportunities, and threats of a potential cardiovascular disease (CVD) screening strategy using CAC in apparently healthy adults.

Recent Findings

CAC is typically used for further CVD risk assessment. CAC is also currently being used as a screening test in specific subgroups of individuals, particularly in some Asian countries. Although this has yielded valuable insights on the determinants and pathophysiology of CVD, whether this approach results in improved clinical outcomes compared to other assessment and management approaches is currently unclear.

Summary

Although CAC and mammograms share a number of characteristics, there are also important conceptual differences. The evidence supporting CAC, which is a robust CVD risk assessment tool, for CVD screening purposes is currently very limited, and further research is needed.
Literatur
1.
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.CrossRefPubMed
2.
3.
4.
Grey C, Jackson R, Schmidt M, Ezzati M, Asaria P, Exeter DJ, et al. One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study (ANZACS-QI 8). Eur Heart J. 2017;38(3):172–80.PubMed
5.
Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1(5):e259–81.CrossRefPubMedPubMedCentral
6.
Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631–9.CrossRefPubMed
7.
Lluis-Ganella C, Subirana I, Lucas G, Tomás M, Muñoz D, Sentí M, et al. Assessment of the value of a genetic risk score in improving the estimation of coronary risk. Atherosclerosis. 2012;222(2):456–63.CrossRefPubMedPubMedCentral
8.
Jeevarethinam A, Venuraju S, Dumo A, Ruano S, Rosenthal M, Nair D, et al. Usefulness of carotid plaques as predictors of obstructive coronary artery disease and cardiovascular events in asymptomatic individuals with diabetes mellitus. Am J Cardiol. 2018;121(8):910–6.CrossRefPubMed
9.
Cainzos-Achirica M, Miedema MD, McEvoy JW, Cushman M, Dardari Z, Greenland P, et al. The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after >10 years of follow-up: the Multi-Ethnic Study of Atherosclerosis (MESA). Int J Cardiol. 2018;264:158–64.CrossRefPubMedPubMedCentral
10.
Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336–45.CrossRefPubMed
11.
Tota-Maharaj R, Blaha MJ, McEvoy JW, Blumenthal RS, Muse ED, Budoff MJ, et al. Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old. Eur Heart J. 2012;33(23):2955–62.CrossRefPubMed
12.
Silverman MG, Blaha MJ, Krumholz HM, Budoff MJ, Blankstein R, Sibley CT, et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J. 2014;35(33):2232–41.CrossRefPubMed
13.
Martin SS, Blaha MJ, Blankstein R, Agatston A, Rivera JJ, Virani SS, et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation. 2014;129(1):77–86.CrossRefPubMed
14.
Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49–73.CrossRefPubMed
15.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2016;37(29):2315–81.CrossRefPubMedPubMedCentral
16.
Hamashima C, Ohta K, Kasahara Y, Katayama T, Nakayama T, Honjo S, et al. A meta-analysis of mammographic screening with and without clinical breast examination. Cancer Sci. 2015;106(7):812–8.CrossRefPubMedPubMedCentral
17.
Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467.CrossRefPubMedPubMedCentral
18.
Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–8.CrossRefPubMed
19.
20.
US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151(10):716–26, W-236.
21.
Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7(1):18–27.CrossRefPubMed
22.
• Qazi AH, Zallaghi F, Torres-Acosta N, Thompson RC, O'Keefe JH. Computed tomography for coronary artery calcification scoring: mammogram for the heart. Prog Cardiovasc Dis. 2016;58(5):529–36. Recent example of the notion of CAC as “mammogram of the heart” in the scientific literature.–36.
23.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–934.CrossRefPubMed
24.
• Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2016;164(4):244–55. Systematic review and meta-analysis of the effectiveness of mammogram for breast cancer screening, conducted by the US Preventive Services Task Force CrossRefPubMed
25.
Paci E, Puliti D, Lopes Pegna A, Carrozzi L, Picozzi G, Falaschi F, et al. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017;72(9):825–31.CrossRefPubMed
26.
27.
28.
Januzzi JL Jr., Suchindran S, Coles A, Ferencik M, Patel MR, Hoffmann U, Ginsburg GS, Douglas PS; PROMISE Investigators. High-sensitivity troponin I and coronary computed tomography in symptomatic outpatients with suspected coronary artery disease: insights from the PROMISE Trial. JACC Cardiovasc Imaging. 2018 Mar 9. pii: S1936-878X(18)30132–3. doi: https://​doi.​org/​10.​1016/​j.​jcmg.​2018.​01.​021. [Epub ahead of print].
29.
• Yeboah J, Young R, McClelland RL, Delaney JC, Polonsky TS, Dawood FZ, et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol. 2016;67(2):139–47. Side by side comparison of several novel CVD risk assessment tools for further CVD risk assessment; among them, CAC showed the best performance. CrossRefPubMedPubMedCentral
30.
McEvoy JW, Blaha MJ, Rivera JJ, Budoff MJ, Khan AN, Shaw LJ, et al. Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification. JACC Cardiovasc Imaging. 2012;5(10):1037–45.CrossRefPubMedPubMedCentral
31.
32.
33.
Cainzos-Achirica M, Rampal S, Chang Y, Ryu S, Zhang Y, Zhao D, et al. Brachial-ankle pulse wave velocity is associated with coronary calcium in young and middle-aged asymptomatic adults: the Kangbuk Samsung Health Study. Atherosclerosis. 2015;241(2):350–6.CrossRefPubMed
34.
Jee SH, Batty GD, Jang Yu BY14, Oh DJ, Oh BH, Lee SH, et al. The Korean Heart Study: rationale, objectives, protocol, and preliminary results for a new prospective cohort study of 430,920 men and women. Eur J Prev Cardiol. 2014;21(12):1484–92.
35.
Zhang Y, Chang Y, Ryu S, Cho J, Lee WY, Rhee EJ, et al. Thyroid hormones and mortality risk in euthyroid individuals: the Kangbuk Samsung health study. J Clin Endocrinol Metab. 2014;99(7):2467–76.CrossRefPubMed
36.
Chang Y, Kim BK, Yun KE, Cho J, Zhang Y, Rampal S, et al. Metabolically-healthy obesity and coronary artery calcification. J Am Coll Cardiol. 2014;63(24):2679–86.CrossRefPubMed
37.
Miedema MD, Petrone A, Shikany JM, Greenland P, Lewis CE, Pletcher MJ, et al. Association of fruit and vegetable consumption during early adulthood with the prevalence of coronary artery calcium after 20 years of follow-up: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation. 2015;132(21):1990–8.CrossRefPubMedPubMedCentral
38.
Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92(13):1081–7.CrossRefPubMed
39.
• Hecht HS, Cronin P, Blaha MJ, Budoff MJ, Kazerooni EA, Narula J, et al. SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Cardiovasc Comput Tomogr. 2016;11(1):74–84. Recommendations from the Society of Cardiovascular Computed Tomography and the Society of Thoracic Radiology for CVD risk assessment using CAC, which include recommendations for CT re-scanning during follow-up. CrossRefPubMed
40.
Al Rifai M, Cainzos-Achirica M, Blaha MJ. Establishing the warranty of a coronary artery calcium score of zero. Atherosclerosis. 2015;238(1):1–3.CrossRefPubMed
41.
Naghavi M, Falk E, Hecht HS, Shah PK, Task Force SHAPE. The first SHAPE (Screening for Heart Attack Prevention and Education) guideline. Crit Pathw Cardiol. 2006;5(4):187–90.CrossRefPubMed
42.
Preventive Services Task Force US. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(7):474–82.CrossRef
43.
• Vonder M, van der Aalst CM, Vliegenthart R, van Ooijen PMA, Kuijpers D, Gratama JW, et al. Coronary artery calcium imaging in the ROBINSCA trial. Rationale, Design, and Technical Background Acad Radiol. 2018;25(1):118–28. Methods of the ROBINSCA trial, which will be aimed at assessing the value of CAC for CVD screening. PubMed
44.
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–32.CrossRefPubMed
45.
Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging. 2009;2(6):692–700.CrossRefPubMed
46.
McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113(1):30–7.CrossRefPubMed
47.
Nasir K, Michos ED, Blumenthal RS, Raggi P. Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol. 2005;46(10):1931–6.CrossRefPubMed
48.
Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis. 2006;184(1):201–6.CrossRefPubMed
49.
McEvoy JW, Diamond GA, Detrano RC, Kaul S, Blaha MJ, Blumenthal RS, et al. Risk and the physics of clinical prediction. Am J Cardiol. 2014;113(8):1429–35.CrossRefPubMed
50.
• Gupta A, Lau E, Varshney R, Hulten EA, Cheezum M, Bittencourt MS, et al. The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2017;10(8):833–42. Systematic review and meta-analysis evaluating the implications of CAC for clinicians and patients in terms of subsequent preventive interventions. CrossRefPubMedPubMedCentral
51.
Byrne D, O’Connor L, Jennings S, Bennett K, Murphy AW. A survey of GPs awareness and use of risk assessment tools and cardiovascular disease prevention guidelines. Irish Med J. 2015;108:204–7.
52.
Reiner Z, Sonicki Z, Tedeschi-Reiner E. Physicians’ perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey. Atherosclerosis. 2010;213:598–603.CrossRefPubMed
53.
54.
55.
Kravchenko J, Berry M, Arbeev K, Lyerly HK, Yashin A, Akushevich I. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Cancer. 2015;88(1):85–93.CrossRefPubMed
56.
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267–78.CrossRefPubMed
57.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–31.CrossRefPubMed
58.
59.
60.
Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011;57(15):1622–32.CrossRefPubMedPubMedCentral
61.
• McEvoy JW, Martin SS, Blaha MJ, Polonsky TS, Nasir K, Kaul S, et al. The Case For and Against a Coronary Artery Calcium Trial: means, motive, and opportunity. JACC Cardiovasc Imaging. 2016;9(8):994–1002. Insightful discussion of the implications and challenges of potential experimental studies assessing CAC-guided CVD risk management strategies. CrossRefPubMed
62.
Ambrosius WT, Polonsky TS, Greenland P, Goff DC Jr, Perdue LH, Fortmann SP, et al. Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power. Clin Trials. 2012;9(2):232–46.CrossRefPubMedPubMedCentral
Metadaten
Titel
Coronary Artery Calcium Score: the “Mammogram” of the Heart?
verfasst von
Miguel Cainzos-Achirica
Philip A. Di Carlo
Catherine E. Handy
Renato Quispe
Gerard Roura
Xavier Pinto
Roger S. Blumenthal
Josep Comin-Colet
Xavier Corbella
Michael J. Blaha
Publikationsdatum
01.09.2018
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 9/2018
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-018-1020-9

Weitere Artikel der Ausgabe 9/2018

Current Cardiology Reports 9/2018 Zur Ausgabe

Peripheral Vascular Disease (CJ Cooper and R Gupta, Section Editors)

Preventing Major Amputations in Patients with Critical Limb Ischemia

Congenital Heart Disease (RA Krasuski, Section Editor)

Preoperative Evaluation of Adult Congenital Heart Disease Patients for Non-cardiac Surgery

Nuclear Cardiology (V Dilsizian, Section Editor)

Fractional Flow Reserve or Coronary Flow Reserve for the Assessment of Myocardial Perfusion

Hypertension (DS Geller and DL Cohen, Section Editors)

The Emerging Role of Mobile-Health Applications in the Management of Hypertension

Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Cardiovascular Risk Assessment in Patients with Hypertriglyceridemia

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise